Business Context and Reporting Period
This Form 8-K filing by 22nd Century Group, Inc. (Nevada) reports a material event occurring on December 23, 2014. The Company, based in Clarence, New York, announced the completion of an acquisition of intellectual property assets.
Key Financial Metrics and Transaction Details
The filing details a specific asset acquisition rather than providing a full set of financial statements (revenue, profit, or cash flow) for a reporting period.
- Asset Acquired: Intellectual property (patents and patent applications) from the National Research Council of Canada (NRC) regarding the modification of nicotine in tobacco plants.
- Total Purchase Price: $1,873,000 USD.
- Cash Paid at Closing: $873,000 paid on December 23, 2014.
- Deferred Payment Obligation: $1,000,000 remaining, payable in three annual installments of approximately $333,333.33 due on December 22, 2015, 2016, and 2017.
Material Changes
The primary material change is the addition of the NRC intellectual property to the Company's balance sheet and the incurrence of a new liability for the deferred purchase price. The filing does not provide comparative financial data or metrics from prior periods to quantify changes in revenue or margins.
Outlook, Risks, and Management Commentary
On December 29, 2014, the Company issued a press release (Exhibit 99.1) providing a business update alongside the transaction announcement. The filing does not contain explicit forward-looking guidance, risk factors, or management commentary within the text of the 8-K itself, referring instead to the attached press release for further details. The transaction is subject to the terms of the Purchase Agreement dated December 22, 2014.
Investor Verification Checklist
- Verify the Company's current liquidity position to ensure it can meet the three future annual installment payments totaling $1,000,000.
- Review the attached Press Release (Exhibit 99.1) for specific details on the strategic application of the acquired nicotine modification technology.
- Confirm the status of the patents and patent applications acquired to assess their commercial viability and remaining legal protection periods.
- Check subsequent filings for any updates on the Company's cash flow or financing activities related to this acquisition.